CNSY
Plus Therapeutics, Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$1.65
−2.94%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1.46x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.29x
- Price / sales
- 2.98x
- Price / cash flow
- -0.56x
Enterprise value
- Enterprise value
- $4.0M
- EV / sales
- 0.95x
- EV / EBITDA
- -0.18x
- EV / EBIT
- -0.15x
- Market cap
- $12.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026